Table 3.
GLADEL–PANLAR recommendations for cardiac and pulmonary manifestations
| Treatment recommendations | Quality of the evidence | Strength of recommendation | 
| Cardiac manifestations | ||
| In adult patients with lupus-related acute pericarditis | ||
| Use SOC plus colchicine over SOC plus NSAIDs or belimumab. | Low | Weak | 
| Pulmonary manifestations | ||
| In adult patient with lupus-related diffuse alveolar haemorrhage | ||
| Use intravenous GCs plus CYC and/or intravenous Ig and/or TPE and/or RTX over GCs alone. | Very low | Strong* | 
*Strong recommendation supported on possible benefits in the context of a life-threatening situation.
CYC, cyclophosphamide; GC, glucocorticoid; GLADEL, Grupo Latino Americano de Estudio del Lupus; Ig, immunoglobulin; NSAID, non-steroidal anti-inflammatory drug; PANLAR, Pan-American League of Associations of Rheumatology; RTX, rituximab; SOC, standard of care; TPE, therapeutic plasma exchange.